Perng et al 40 observed significant improvement in health-related quality of life following triple therapy compared with LABA+ICS; while our analysis did not reach statistical significance, triple therapy was ranked higher than LABA+ICS in SUCRA analysis.
← all excerpts
Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis.
1
—
—